Medication info
Dafor Tablets 10 mg (Dapagliflozin bis L-proline)

Dafor Tablets 10 mg (Dapagliflozin bis L-proline)

Prescription medicationTablet경구
Ingredient · strength
Dapagliflozin Bis L-proline›15.63mg / 1 tablet
Manufacturer / importer
일동제약(주)
Appearance
Yellow, convex diamond-shaped film-coated tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202003736 · Approved 2020.05.22 · Insurance code 642906810

Summary

Main use
Blood sugar control in type 2 diabetes and prevention of cardiovascular events
Who takes it
Adults · Children
Adult dose
For monotherapy and add-on therapy in type 2 diabetes, the dosage is 10 mg once daily. In initial combination therapy, for those with no prior experience of diabetes drug treatment, it is 5 mg or 10 mg once daily when combined with metformin. In special populations, for patients with severe liver impairment, a starting dose of 5 mg is recommended, and if well tolerated, it can be increased to 10 mg. For patients with renal impairment: eGFR 45 mL/min/1.
Child dose
Safety and effectiveness in children under 18 years of age have not been established; thus, it is not recommended.

Ingredients

Manufacturer
일동제약(주)

Efficacy & effects

Blood sugar control in type 2 diabetes and prevention of cardiovascular events

  • Type 2 diabetes
  • abnormal blood sugar control
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be used in conjunction with dietary and exercise therapies or alone. It is especially used for patients who do not achieve sufficient blood sugar control, including those with cardiovascular disease or risk factors. It helps improve both blood sugar management and cardiovascular health in patients. This medication plays an important role in the treatment of type 2 diabetes.

How to take

Adult dose

For monotherapy and add-on therapy in type 2 diabetes, the dosage is 10 mg once daily. In initial combination therapy, for those with no prior experience of diabetes drug treatment, it is 5 mg or 10 mg once daily when combined with metformin. In special populations, for patients with severe liver impairment, a starting dose of 5 mg is recommended, and if well tolerated, it can be increased to 10 mg. For patients with renal impairment: eGFR 45 mL/min/1.

Child dose

Safety and effectiveness in children under 18 years of age have not been established; thus, it is not recommended.

Precautions

This medication should not be used in patients with hypersensitivity to the active ingredients or excipients, type 1 diabetes, diabetic ketoacidosis, or genetic issues such as lactose intolerance. It should also not be administered to patients undergoing dialysis. Caution should be exercised when this medication is used in patients with reduced fluid volume or renal dysfunction. This medication can lower blood pressure or reduce intravascular volume, which may cause hypotension or changes in kidney function. Special attention is required for patients with impaired kidney function, the elderly, and those taking diuretics, and fluid status and kidney function should be closely monitored before and after administration. This medication may cause various side effects, including genital infections, urinary tract infections, hypoglycemia, dizziness, dry mouth, back pain, painful urination, polyuria, nocturia, increased hematocrit, elevated blood creatinine, elevated blood urea, weight loss, rash, chest pain, weakness, pain, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like symptoms, itching, urticaria, cold sweats, abdominal pain, dyspepsia, and nausea. Genital infections and urinary tract infections are particularly commonly reported, and if such symptoms occur, prompt treatment is necessary. When used with medications that can cause hypoglycemia, such as insulin or sulfonylureas, there may be an increased risk of hypoglycemia, so adjustments to the doses of these medications may be necessary. It is advisable for pregnant or nursing women to avoid using this medication, and if pregnancy is confirmed, administration should be discontinued immediately. This medication does not significantly affect the ability to drive or operate machinery; however, caution is required due to the risk of hypoglycemia when combined with medications such as insulin. Finally, the safety and efficacy of this medication in children have not been sufficiently established, so it is recommended not to use it in pediatric patients. When using this medication, it is essential to follow the physician's guidance, and it is important to seek immediate consultation if any abnormal symptoms occur.

Side effects and when to seek care immediately

Serious side effects

Decreased fluid volume (dehydration, hypovolemia, hypotension), diabetic ketoacidosis, acute renal injury and renal dysfunction, perineal necrosis (Fournier's gangrene), anaphylaxis, urticaria, angioedema, severe swelling (edema), rash (severe skin adverse reactions), cold sweats, chest tightness, difficulty breathing, severe allergic reactions, severe skin adverse reactions, respiratory problems, liver abnormalities (jaundice), severe neurological symptoms, severe edema

Mild side effects

Vulvovaginitis, balanitis and associated genital infections, urinary tract infections, fungal infections, hypoglycemia, dry mouth, dizziness, constipation, back pain, painful urination, polyuria, nocturia, increased hematocrit, elevated blood creatinine, elevated blood urea, weight loss, rash, chest pain, weakness, pain, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like symptoms, itching, urticaria, cold sweats, abdominal pain, dyspepsia, nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is best to keep the medication at room temperature between 1 degree and 30 degrees Celsius, avoiding excessively hot or cold environments.

Appearance and packaging

Appearance

Yellow, convex diamond-shaped film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.